Clinical Trial Update: FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated FT538 in combination with daratumumab in acute myeloid leukemia, including monocytic leukemia, and has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Monocytic Leukemia

Drugs mentioned

• Daratumumab (daratumumab)
• FT538

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myeloid Leukemia, Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2024-10-24